Upcoming Medical Conferences in DuarteSearch Criteria : United States of America Duarte
Apr 05 - 06, 2019 | Duarte, California
8th Annual Clinical Cancer Genetics and Genomics Conference is organized by Meeting Achievements and will be held from Apr 05 - 06, 2019 at City of Hope Comprehensive Cancer Center - Duarte, Duarte, California, United States of America. Target Audience: This activity has been designed for physicians, physician assistants, advanced nurse practitioners, genetic counselors, oncology nurses, and other health care professionals currently involved in providing cancer genetics risk assessment services or initiating such services in their health care system. Special efforts will be made to meet the needs of clinicians practicing in non-academic centers and geographically and/or socioeconomically underserved communities. Description: Identifying hereditary cancer predisposition through genomic cancer risk assessment (GCRA) allows for intensified measures to prevent cancers or detect them at an earlier, more treatable stage, and both germline and somatic/tumor testing may guide precision therapy. The rapid advances of next generation sequencing (NGS) technologies and market forces are driving a surge in demand for GCRA services across the nation, but few clinicians are adequately prepared with the knowledge and skills needed to address the complexities associated with multigene panel testing, polygenic risk scores (PRS), and approaches that combine tumor and germline genomic profiles. This two-day conference will bring a roster of nationally recognized speakers together with community-based clinicians from across the U.S. and internationally to explore the promise and challenge of incorporating NGS technologies into the landscape of personalized cancer risk assessment, treatment and preventive care. This activity will provide an interdisciplinary educational forum in which to update state-of-the-art science, discuss real-world cases, curate interesting pedigrees and prepare case summaries to disseminate new knowledge in translational genomics and evidence-based clinical management of high-risk patients and their family members. The goal is to improve detection of cancer syndromes and prevent cancer morbidity and mortality. Additional details will be posted as soon as they are available.